Key facts
- A novel pancreatic cancer pill showed survival gains in a trial.
- The drug nearly doubled survival time for patients.
- The results have surprised experts.
A breakthrough trial for a novel pancreatic cancer pill has yielded surprising results, with the drug nearly doubling survival time for patients. The efficacy of this new treatment has exceeded expectations, offering a significant advancement in the fight against pancreatic cancer. This development is particularly noteworthy given the historically poor prognosis associated with this disease.